<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="110945">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01896765</url>
  </required_header>
  <id_info>
    <org_study_id>BIHKF-7161</org_study_id>
    <nct_id>NCT01896765</nct_id>
  </id_info>
  <brief_title>Intensive Prevention Program After Myocardial Infarction</brief_title>
  <acronym>IPP</acronym>
  <official_title>Intensive Longterm Prevention Program After Myocardial Infarction in Northwest Germany</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herzzentrum Bremen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oldenburger Forschungs- und Entwicklungsinstitut f√ºr Informatik (OFFIS).</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Herzzentrum Bremen</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is unknown, if a modern prevention program, including intense nurse-coordinated education
      sessions, regular telephone contacts and a telephone hotline for 12 months, significantly
      reduces cardiovascular risk factors, clinical events and quality of life in myocardial
      infarction patients compared to usual care. Furthermore, actually no data on the additional
      effects and the feasibility of longterm telemetric care of cardiovascular risk factors
      exist.

      The primary hypothesis to be tested is that an intensive longterm prevention program
      compared to the standard of medical care, will achieve better risk factor control and
      consecutively less clinical adverse events in patients after myocardial infarctions. A
      nurse-coordinated program and telemetric prevention will be analyzed.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Prevention score (point score of cardiovascular risk factors)</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Combined endpoint of clinical adverse events</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to prognostic relevant medication after myocardial infarction</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Myocardial Infarction.</condition>
  <condition>Prevention Harmful Effects.</condition>
  <arm_group>
    <arm_group_label>Intensive prevention program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard care with respect to medical and interventional therapy plus intensive prevention program with &quot;study nurse&quot;-coordinated education sessions, regular telephone calls, telephone hotline and telemetric care of cardiovascular risk factors (if patient internet connection available).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard care with respect to medical and interventional therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intensive Prevention Program</intervention_name>
    <description>&quot;Study nurse&quot;-coordinated education sessions, telephone calls, telephone hotline and telemetric care of cardiovascular risk factors (if patient internet connection available).</description>
    <arm_group_label>Intensive prevention program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard medical and interventional therapy</intervention_name>
    <description>Medical and interventional therapy following the standard of care.</description>
    <arm_group_label>Intensive prevention program</arm_group_label>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Hospitalisation due to myocardial infarction (ST-elevation or non-ST-elevation myocardial
        infarction)

        Exclusion Criteria:

        i) Hemodynamically significant valvular heart disease (&gt; NYHA class II) or inborn cardiac
        malformations.

        ii) Cardiomyopathy associated with hemodynamic obstruction, pregnancy or myocarditis.

        iii) Exercise limitations due to clinical conditions not related to CAD. iv) Any major
        non-cardiac condition that would adversely effect survival during the duration of the
        study.

        v) Patients unlikely to comply to the study treatment and the follow-up visits. vi)
        Pregnancy (all pre-menopausal females should have a negative serum pregnancy test).

        vii) Inability of cooperation with the protocol, including longterm follow-up. viii)
        Patient refusal or inability to give informed consent. ix) Refusal of the patient's
        physician regarding trial participation of the patient.

        x) Chronic drug or alcohol abuse.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Harm Wienbergen, MD</last_name>
    <phone>01149 421 879 4059</phone>
    <email>harm.wienbergen@klinikum-bremen-ldw.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rainer Hambrecht, MD</last_name>
    <phone>01149 421 879 1430</phone>
    <email>rainer.hambrecht@klinikum-bremen-ldw.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Herzzentrum Bremen</name>
      <address>
        <city>Bremen</city>
        <zip>28277</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Harm Wienbergen, MD</last_name>
      <phone>01149 421 879 4059</phone>
      <email>harm.wienbergen@klinikum-bremen-ldw.de</email>
    </contact>
    <investigator>
      <last_name>Harm Wienbergen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 11, 2013</lastchanged_date>
  <firstreceived_date>July 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
